ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Shares in Issue
Live Quote
 
 

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, its principle place of business is in the United Kingdom. 

The Total Number of shares in issue is 336,516,457.  The percentage of securities not in public hands is 16.20%. The shareholders who hold more than 3% are as follows:

 

Shareholders

Number of Shares

Percentage of Total

Pershing Nominees Limited

33,659,049

10.00%

Raven Nominees Limited

15,049,981

  4.47%

Prism Nominees Limited

20,448,554

  6.08%

LR Nominees Limited

11,904,708

  3.54%

JIM Nominees Limited

27,144,419

   8.07%

Fortis Nominees Limited

19,909,038

   5.77%

Hargreaves Hale Nominees Ltd

26,131,532

   7.77%

TD Waterhouse Nominees Ltd

10,909,038

   3.24%

Directors

54,507,908

16.20%